Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVOLUTION: VDR vs VDCR vs VDC in Untreated Multiple Myeloma
NCT00507442Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Aug 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in multiple myeloma (MM), sponsored by Millennium Pharmaceuticals. Started Aug 2007; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00507442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00507442.